Virtual event

Metabolite biomarkers in the development of anticancer drugs

By entering your contact details you agree to our Privacy policy.

Event speaker

Group leader pharmacokinetics and metabolomics

Institute of Cancer Research, Sutton, UK

Why metabolomics is an essential part of drug studies
How to design pharmacological experiments with comprehensive and measurable endpoints
How the development cycle of anticancer drugs can be shortened significantly by choosing the right experiments in the early developmental stages